Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40-70 years of age. (Q50945932)
Jump to navigation
Jump to search
scientific article published on 30 May 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40-70 years of age. |
scientific article published on 30 May 2013 |
Statements
Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40-70 years of age. (English)
1 reference
William L Heyward
1 reference
Michael Kyle
1 reference
Joseph Blumenau
1 reference
Matthew Davis
1 reference
Keith Reisinger
1 reference
Martin L Kabongo
1 reference
Sean Bennett
1 reference
Robert S Janssen
1 reference
Hamid Namini
1 reference
J Tyler Martin
1 reference
30 May 2013
1 reference
1 reference
31
1 reference
46
1 reference
5300-5305
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference